gbt
announce
third
quarter
financial
results
thursday
november
south
san
francisco
globe
newswire
global
blood
therapeutics
gbt
nasdaq
gbt
today
announced
report
third
quarter
financial
results
thursday
november
financial
markets
close
management
host
conference
call
thursday
november
et
provide
general
business
update
discuss
third
quarter
financial
results
participate
conference
call
please
dial
domestic
international
live
audio
webcast
conference
call
accessed
gbt
website
investors
section
archived
audio
webcast
available
one
month
following
event
global
blood
therapeutics
global
blood
therapeutics
gbt
biopharmaceutical
company
dedicated
discovery
development
delivery
treatments
provide
hope
underserved
patient
communities
founded
gbt
delivering
goal
transform
treatment
care
sickle
cell
disease
scd
lifelong
devastating
inherited
blood
disorder
company
introduced
voxelotor
first
treatment
directly
inhibits
sickle
hemoglobin
polymerization
root
cause
red
blood
cell
sickling
scd
gbt
also
advancing
pipeline
program
scd
inclacumab
inhibitor
development
address
pain
crises
associated
disease
addition
gbt
drug
discovery
teams
working
new
targets
develop
next
generation
treatments
scd
learn
please
visit
follow
company
twitter
contact
information
steven
immergut
investors
media
simmergut
